In ovarian cancer (OC) patients, point mutations or amplifications of the PIK3CA gene, which encodes the p110α catalytic subunit of the PI3K complex, are present in >20% of all OC types3–6. This evidence concerns the gene PIK3CD and ovarian cancer.